Qingdao Baheal Medical INC. (301015) — Cash Flow Reinvestment Rate
Qingdao Baheal Medical INC. (301015) has a Cash Flow Reinvestment Rate of 0.47x as of September 2025, reinvesting CN¥107.50 Million (capex CN¥107.50 Million ) from operating cash flow of CN¥230.38 Million. Explore Qingdao Baheal Medical INC. (301015) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Qingdao Baheal Medical INC. Cash Flow Reinvestment Rate (2018–2025)
Historical reinvestment intensity for Qingdao Baheal Medical INC. across 7 annual periods. Also explore balance sheet size of Qingdao Baheal Medical INC. for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Qingdao Baheal Medical INC. (2018–2025)
Year-by-year capital reinvestment analysis for Qingdao Baheal Medical INC.. For live market cap and broader valuation context, see 301015 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.63x | CN¥589.21 Million | CN¥934.45 Million | CN¥288.93 Million | ▼ -30.1% |
| 2024 | 0.90x | CN¥734.15 Million | CN¥813.85 Million | CN¥303.99 Million | ▲ +109.0% |
| 2023 | 0.43x | CN¥345.01 Million | CN¥799.50 Million | CN¥185.49 Million | ▼ -40.7% |
| 2022 | 0.73x | CN¥222.65 Million | CN¥305.75 Million | CN¥105.32 Million | ▲ +162.4% |
| 2021 | 0.28x | CN¥50.31 Million | CN¥181.30 Million | CN¥27.49 Million | ▲ +92.5% |
| 2019 | 0.14x | CN¥6.63 Million | CN¥45.96 Million | CN¥2.95 Million | ▼ -49.2% |
| 2018 | 0.28x | CN¥15.74 Million | CN¥55.50 Million | CN¥15.74 Million | — |